Changes in Utilization and Discard of Hepatitis C–Infected Donor Livers in the Recent Era
Mary G. Bowring(Johns Hopkins University), Christine M. Durand(University of Maryland, Baltimore), Allan B. Massie(Johns Hopkins University), Katie Rakestraw(Johns Hopkins University), Andrew M. Cameron(Johns Hopkins University), Dorry L. Segev(New York University), Mark Sulkowski(Johns Hopkins University), Lauren M. Kucirka(Johns Hopkins University), Xun Luo(Hunan Provincial People's Hospital), Irene Kuo(George Washington University), Ahmet Gürakar(Johns Hopkins University)
Cited by 105
Related Papers
Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection†‡
|Hepatology|2006|4.8k
Voriconazole versus Amphotericin B for Primary Therapy of Invasive Aspergillosis
|New England Journal of Medicine|2002|3.3k
Sofosbuvir for Hepatitis C Genotype 2 or 3 in Patients without Treatment Options
|New England Journal of Medicine|2013|1.1k